..., Academic Press, 1990, pp 167-184. 10. Varga Z, Jacob M-P, Robert L, Fülöp T Jr: Identification and signal transduction mechanism of elastin peptide receptor in human leucocytes. FEBS 1989;258:5-8. 11. Hill SJ, Kendall DA: Cross-talk between different receptor-effector systems in the mammalian CNS...

... quality of life for elderly subjects. Acknowledgments This work is partly supported by grants from the Canadian Institutes of Health Research (No. 106634 and No. 106701), the Université de Sherbrooke, and the Research Center on Aging. References References 1. Müller L, Fülöp T, Pawelec G...

..., John Wiley & Sons, 2007. 25. Comfort A: The Biology of Senescence. London, Churchill Livingstone, 1979. 26. Robert L, Robert AM, Fülöp T: Rapid increase in human life expectancy: will it soon be limited by the aging of elastin? Biogerontology 2008;9:119-133. 27. Jacob M-P, Hornebeck W...

... for activation and inhibition. Annu Rev Immunol 2013;31:227–258. 37. Le Page A, Bourgade K, Lamoureux J, Frost E, Pawelec G, Larbi A, Witkowski JM, Dupuis G, Fülöp T: NK Cells are activated in amnestic mild cognitive impairment but not in mild Alzheimer’s disease patients. J Alzheimers Dis 2015;46:93–107...

...: possible decrements in second messenger function and calcium mobilization; in Bergener M, Emini M, Stähelin HB (eds): The 1990 Sandoz Lectures in Gerontology. Challenges in Aging. New York, Academic Press, 1990, pp 167-184. 10. Varga Z, Jacob M-P, Robert L, Fülöp T Jr: Identification and signal...

... Affairs Population Division: World Population Ageing. New York, United Nations, 2013. 2. Robert L, Fulop T (eds): Aging: Facts and Theories. Intrdisc Top Geriatr Gerontol. Basel, Karger, 2014, vol 39, pp 62-85. 3. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G: The hallmarks of aging...

... history. Curr Biol 2011;21:R701-R707. 21959160 10.1016/j.cub.2011.07.020 18. Strehler BL, Mildvan AS: General theory of mortality and aging. Science 1960;132:14-21. 13835176 10.1126/science.132.3418.14 19. Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, Pawelec G: Aging...

... and cancer cell biology. Aging Cell 2009;8:221-225 6. Salvioli S, Capri M, Bucci L, et al: Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother 2009;58:1909-1917 7. Fülöp T, Larbi A, Hirokawa K, et al: Immunosupportive therapies in aging...

...References References 1. Müller L, Fülöp T, Pawelec G: Origins of the mammalian immune system and implications for immunosenescence. Immun Aging 2013;10:12. 2. Walford RL: Immunologic aspects of aging. Klin Wochenschr 1969;47:599-605. 3. Mócsai A: Diverse novel functions...

...References References 1. Department of Economic and Social Affairs Population Division: World Population Ageing. New York, United Nations, 2013. 2. Robert L, Fulop T (eds): Aging: Facts and Theories. Intrdisc Top Geriatr Gerontol. Basel, Karger, 2014, vol 39, pp 62-85. 3. López-Otín C...

... 6. Salvioli S, Capri M, Bucci L, et al: Why do centenarians escape or postpone cancer? The role of IGF-1, inflammation and p53. Cancer Immunol Immunother 2009;58:1909-1917 7. Fülöp T, Larbi A, Hirokawa K, et al: Immunosupportive therapies in aging. Clin Interv Aging 2007;2:33-54 8. Larbi...

... decline however with age, as discussed by T. Fulop (this vol.). Another possibility for the age-dependent increase in the number of senescent cells with age is the probability of increased damage frequency and severity, oncogenic mutations and other senescence-inducing events. The previously cited...

... Gerontol Geriatr 1982;1:29-42. 97. Zs.-Nagy I, SemseI I: Centrophenoxine increases the rates of total and mRNA synthesis in the brain cortex of old rats, an explanation of its action in terms of the membrane hypothesis of aging. Exp Gerontol 1984;19:171-178. 98. Pék Gy, Fülöp T Jr, Zs.-Nagy I...